Trends in the Use and Costs of Medications for Respiratory Management Included in the 2022 Benefit Plan of the Colombia Health System

• by Manuel Enrique Machado-Duque, Luis Fernando Valladales-Restrepo, Andrés Gaviria-Mendoza, Juan Pablo Albanes-Beltrán, Giovanny Mesa-Escobar, Ana Camila Delgado-Araujo, María Camila Oyuela-Gutiérrez, Santiago Rubio-Londoño, Jorge Enrique Machado-Alba

• September 14, 2026

Rethinking Pediatric Asthma Education Through Large Language Model Generation and Simplification: Randomized Double-Blind Study

• by Tianyi Xu, Yong Yin, Xi Zhang, Wei Wei, Jiajun Yuan, Hansong Wang, Guodong Ding, Wenjie Xue, Ziwei Chen, Sixin Xie, Huiqin Niu, Jie Xi, Shuzhu Lin, Xiaoli Tang, Liebin Zhao

• August 26, 2026

Beta-2 Agonists Tied to ASD Risk?

Systematic review of 8 observational studies found limited evidence on associations between prenatal asthma-medication exposure and neurodevelopmental outcomes, with autism spectrum disorder the only outcome suitable for meta-analysis.

• by Andrea Surnit

• June 24, 2026

• 4 min

Language Disparities in the PFT Lab: Implications for PFT Lab Quality Performance

• by David A. Kaminsky

• July 14, 2026